193 related articles for article (PubMed ID: 16969262)
21. Dual-time point 18FDG-PET/CT imaging may be useful in assessing local recurrent disease in high grade bone and soft tissue sarcoma.
Dancheva Z; Bochev P; Chaushev B; Yordanova T; Klisarova A
Nucl Med Rev Cent East Eur; 2016; 19(1):22-7. PubMed ID: 26841376
[TBL] [Abstract][Full Text] [Related]
22. Is FDG-PET/CT Useful for Diagnosing Pulmonary Metastasis in Patients with Soft Tissue Sarcoma?
Hagi T; Nakamura T; Sugino Y; Matsubara T; Asanuma K; Sudo A
Anticancer Res; 2018 Jun; 38(6):3635-3639. PubMed ID: 29848720
[TBL] [Abstract][Full Text] [Related]
23. Assessment of pulmonary melanoma metastases with 18F-FDG PET/CT: which PET-negative patients require additional tests for definitive staging?
Mayerhoefer ME; Prosch H; Herold CJ; Weber M; Karanikas G
Eur Radiol; 2012 Nov; 22(11):2451-7. PubMed ID: 22653282
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of fluorodeoxyglucose positron emission tomography in the management of soft-tissue sarcomas.
Lucas JD; O'Doherty MJ; Wong JC; Bingham JB; McKee PH; Fletcher CD; Smith MA
J Bone Joint Surg Br; 1998 May; 80(3):441-7. PubMed ID: 9619933
[TBL] [Abstract][Full Text] [Related]
25. Accuracy of 18F fluorodeoxyglucose positron emission tomography/computed tomography in staging of pediatric sarcomas.
Tateishi U; Hosono A; Makimoto A; Sakurada A; Terauchi T; Arai Y; Imai Y; Kim EE
J Pediatr Hematol Oncol; 2007 Sep; 29(9):608-12. PubMed ID: 17805034
[TBL] [Abstract][Full Text] [Related]
26. Tumour assessment in advanced melanoma: value of FDG-PET/CT in patients with elevated serum S-100B.
Strobel K; Skalsky J; Kalff V; Baumann K; Seifert B; Joller-Jemelka H; Dummer R; Steinert HC
Eur J Nucl Med Mol Imaging; 2007 Sep; 34(9):1366-75. PubMed ID: 17390135
[TBL] [Abstract][Full Text] [Related]
27. FDG-PET for detection of pulmonary metastases from malignant primary bone tumors: comparison with spiral CT.
Franzius C; Daldrup-Link HE; Sciuk J; Rummeny EJ; Bielack S; Jürgens H; Schober O
Ann Oncol; 2001 Apr; 12(4):479-86. PubMed ID: 11398879
[TBL] [Abstract][Full Text] [Related]
28. 18F-FDG PET-CT in soft tissue sarcomas: staging, restaging, and prognostic value?
Gabriel M; Rubello D
Nucl Med Commun; 2016 Jan; 37(1):3-8. PubMed ID: 26457597
[TBL] [Abstract][Full Text] [Related]
29. Combined 18F-NaF and 18F-FDG PET/CT in the Evaluation of Sarcoma Patients.
Jackson T; Mosci C; von Eyben R; Mittra E; Ganjoo K; Biswal S; Gambhir SS; Iagaru A
Clin Nucl Med; 2015 Sep; 40(9):720-4. PubMed ID: 26053718
[TBL] [Abstract][Full Text] [Related]
30. F-18 FDG PET and PET/CT evaluation of response to chemotherapy in bone and soft tissue sarcomas.
Iagaru A; Masamed R; Chawla SP; Menendez LR; Fedenko A; Conti PS
Clin Nucl Med; 2008 Jan; 33(1):8-13. PubMed ID: 18097248
[TBL] [Abstract][Full Text] [Related]
31. Whole-body F-18-fluoro-2-deoxyglucose positron emission tomography/computed tomography imaging in the follow-up of metastatic uveal melanoma.
Klingenstein A; Haug AR; Nentwich MM; Tiling R; Schaller UC
Melanoma Res; 2010 Dec; 20(6):511-6. PubMed ID: 20890225
[TBL] [Abstract][Full Text] [Related]
32. PET recognition of pulmonary metastases on PET/CT imaging: impact of attenuation-corrected and non-attenuation-corrected PET images.
Reinhardt MJ; Wiethoelter N; Matthies A; Joe AY; Strunk H; Jaeger U; Biersack HJ
Eur J Nucl Med Mol Imaging; 2006 Feb; 33(2):134-9. PubMed ID: 16193313
[TBL] [Abstract][Full Text] [Related]
33. FDG PET/CT imaging in primary osseous and soft tissue sarcomas: a retrospective review of 212 cases.
Charest M; Hickeson M; Lisbona R; Novales-Diaz JA; Derbekyan V; Turcotte RE
Eur J Nucl Med Mol Imaging; 2009 Dec; 36(12):1944-51. PubMed ID: 19593561
[TBL] [Abstract][Full Text] [Related]
34. Teflon-induced granuloma: a source of false positive positron emission tomography and computerized tomography interpretation.
Hewitt RJ; Singh A; Wareing MJ
J Laryngol Otol; 2004 Oct; 118(10):822-4. PubMed ID: 15550194
[TBL] [Abstract][Full Text] [Related]
35. [Surgical treatment of primary pulmonary cryptococcosis].
Wang T; Sun YE; Yu CH; Yang B; Sun K; Zhou ZH
Zhonghua Wai Ke Za Zhi; 2005 Nov; 43(22):1447-9. PubMed ID: 16318811
[TBL] [Abstract][Full Text] [Related]
36. Clinical value of including the head and lower extremities in 18F-FDG PET/CT imaging for patients with malignant melanoma.
Niederkohr RD; Rosenberg J; Shabo G; Quon A
Nucl Med Commun; 2007 Sep; 28(9):688-95. PubMed ID: 17667747
[TBL] [Abstract][Full Text] [Related]
37. A case of pulmonary synovial sarcoma diagnosed with detection of chimera gene: imaging findings.
Matsuo Y; Sakai S; Yabuuchi H; Soeda H; Takahashi N; Okafuji T; Yoshimitsu K; Koga H; Yoshino I; Oda Y; Nakamura Y; Honda H
Clin Imaging; 2006; 30(1):60-2. PubMed ID: 16377488
[TBL] [Abstract][Full Text] [Related]
38. Lung sequestration and Pott disease masquerading as primary lung cancer with bone metastases on FDG PET/CT.
Su M; Fan Q; Fan C; Tian Y; Li F; Yang X; Zhuang H
Clin Nucl Med; 2009 Apr; 34(4):236-8. PubMed ID: 19300056
[TBL] [Abstract][Full Text] [Related]
39. Diagnostic usefulness of 18F-FDG PET/CT in the differentiation of pulmonary artery sarcoma and pulmonary embolism.
Ito K; Kubota K; Morooka M; Shida Y; Hasuo K; Endo H; Matsuda H
Ann Nucl Med; 2009 Sep; 23(7):671-6. PubMed ID: 19680740
[TBL] [Abstract][Full Text] [Related]
40. Prospective evaluation of soft tissue masses and sarcomas using fluorodeoxyglucose positron emission tomography.
Lucas JD; O'Doherty MJ; Cronin BF; Marsden PK; Lodge MA; McKee PH; Smith MA
Br J Surg; 1999 Apr; 86(4):550-6. PubMed ID: 10215835
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
